SHANGHAI, Oct. 23, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received China Food and Drug Administration approval for the Alair® Bronchial Thermoplasty System, an innovative medical device designed to treat severe asthma. Expected to be available in the......
More...
